Supplementary Figure S3 from Homoharringtonine Added to Venetoclax and Azacitidine Improves Outcome and Mitigates Genetic Impact in Relapsed/Refractory AML: A Multicenter Cohort Study
Open Access
- 6 January 2025
- other
- Published by American Association for Cancer Research (AACR)